Press releaseGlobe Newswire
Stereotaxis
STXS · NYSE American
$0.9983−$0.0117 (−1.16%)TodayMarket closed ·
Prev close $1.01
Latest news
- Press releaseGlobe Newswire
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
- Press releaseGlobe Newswire
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
- Press releaseGlobe Newswire
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
Stereotaxis Completes Acquisition of Robocath
- News
Stereotaxis Q1 2026 Earnings Call Transcript
- Press releaseGlobe Newswire
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
- News
Earnings Scheduled For May 12, 2026
- Press releaseGlobe Newswire
Stereotaxis Announces First MAGiC Procedures in the United States
- NewsVandana Singh
Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover
- Press releaseGlobe Newswire
Stereotaxis Announces Definitive Agreement to Acquire Robocath
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
Stereotaxis Q4 Earnings Summary & Key Takeaways
- News
Earnings Scheduled For March 9, 2026
- News
Preview: Stereotaxis's Earnings
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
Earnings Scheduled For November 11, 2025
- News
A Look at Stereotaxis's Upcoming Earnings Report
- NewsTriveni Kothapalli
New Robotic System Promises Faster, Safer Care For Arrhythmia Patients
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.